Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DOACs for catheter-induced thrombosis prophylaxis
NCT05705076Unknown
- Sponsor
- Mansoura University
- Start
- Jan 2023
- Primary completion
- Mar 2024
- Modality
- Small Molecules
01
Overview
Randomised, double-blind trial of apixaban and rivaroxaban in thrombosis, sponsored by Mansoura University. Primary endpoint: Thromboprophylaxis of catheter induced thrombosis at 6 months. Status: unknown.
02
Drugs
apixabanrivaroxaban
03
Conditions
thrombosis
Beyond the preview
Go deeper on NCT05705076.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05705076.